• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ginkgo Bioworks Hldgs Inc (NY: DNA )

    7.750 +0.130 (+1.71%)
    Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Ginkgo Bioworks Hldgs Inc

    < Previous 1 2
    ...
    10 11 12 13 14 15 16 17 Next >
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors
    From Cruz The Law Offices of Frank R. Cruz
    Via Business Wire
    INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    GINKGO BIOWORKS INVESTOR ALERT - Investors Who Have Suffered Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.
    PHILADELPHIA, PA / ACCESSWIRE / October 6, 2021 / Kehoe Law Firm, P.C. is investigating whether Ginkgo Bioworks ("Ginkgo" or the "Company") (NYSE:DNA) violated federal securities laws. Ginkgo investors... 
    From Kehoe Law Firm, P.C.
    Via AccessWire
    Topics Fraud
    Exposures Legal
    DNA Stock: 7 Things to Know About the Short Report Hammering Ginkgo Bioworks
    Today, Ginko Bioworks and DNA stock are firmly in the sights of short-sellers as various claims are made about an elaborate fraud underway. 
    Via InvestorPlace
    Topics Fraud
    Exposures Legal
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    Ginkgo Bioworks Stock Drops 20% After Short Sellers Call Company A 'Colossal Scam'
    Shares of synthetic biology company Ginkgo Bioworks Holdings Inc (NYSE: 
    Via Benzinga
    26 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares jumped 54.1% to $3.8050 after the company announced licensing option agreement with Pfizer for capsids generated from... 
    Via Benzinga
    Here's Why This Cathie Wood Stock Is Crashing Today
    Scorpion Capital is shooting some venom at a new target today. 
    Via The Motley Fool
    DNA INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Ginkgo Bioworks Holdings, Inc. Investors with Losses to Inquire About Class Action Investigation – DNA
    From Rosen Law Firm
    Via Business Wire
    Mid-Morning Market Update: Markets Open Lower; Acuity Brands Posts Upbeat Q4 Results
    Following the market opening Wednesday, the Dow traded down 1.12% to 33,929.34 while the NASDAQ fell 0.69% to 14,334.78. The S&P also fell, dropping 0.90% to 4,306.41. The U.S... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Here's an Up-and-Coming Biotech Stock to Watch With a Cannabis Connection
    And it has a really great ticker that many other biotechs might envy. 
    Via The Motley Fool
    Topics Cannabis
    Exposures Cannabis
    Why Shares of Ginkgo Bioworks Are Rising Today
    A new analyst rating has investors excited. 
    Via The Motley Fool
    Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2021
    Upgrades For Methanex Corp (NASDAQ: 
    Via Benzinga
    DNA Stock Cooks Up 10% Gains on Ginkgo Biowork’s First Trading Day
    Ginkgo Bioworks knows about growth and so far, it seems as though DNA stock does as well as it kicks off under an aptly titled ticker. 
    Via InvestorPlace
    SRNG, DNA: 14 Things to Know About Ginkgo Bioworks and the Soaring Eagle SPAC Merger
    Ginkgo Bioworks (DNA) stock is set to start trading today as the company completes its merger with SPAC Soaring Eagle (SRNG). 
    Via InvestorPlace
    < Previous 1 2
    ...
    10 11 12 13 14 15 16 17 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.